PL384304A1 - Pochodne fenoksyalkiloaminoalkanoli i ich zastosowania - Google Patents

Pochodne fenoksyalkiloaminoalkanoli i ich zastosowania

Info

Publication number
PL384304A1
PL384304A1 PL384304A PL38430408A PL384304A1 PL 384304 A1 PL384304 A1 PL 384304A1 PL 384304 A PL384304 A PL 384304A PL 38430408 A PL38430408 A PL 38430408A PL 384304 A1 PL384304 A1 PL 384304A1
Authority
PL
Poland
Prior art keywords
aminoalkanols
derivatives
phenoxyalkiloaminoalkanols
applications
phenoxy
Prior art date
Application number
PL384304A
Other languages
English (en)
Other versions
PL212489B1 (pl
Inventor
Katarzyna Kieć-Kononowicz
Henryk Marona
Anna Maria Waszkielewicz
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL384304A priority Critical patent/PL212489B1/pl
Priority to CA2712222A priority patent/CA2712222C/en
Priority to EP09704454.9A priority patent/EP2247571B1/en
Priority to KR1020107016398A priority patent/KR101610972B1/ko
Priority to ES09704454.9T priority patent/ES2525544T3/es
Priority to DK09704454.9T priority patent/DK2247571T3/en
Priority to BRPI0905726-9A priority patent/BRPI0905726A2/pt
Priority to RU2010133174/04A priority patent/RU2515213C2/ru
Priority to JP2010544256A priority patent/JP5683965B2/ja
Priority to US12/863,881 priority patent/US8633251B2/en
Priority to CN2009801026627A priority patent/CN101932551A/zh
Priority to CN201610282236.8A priority patent/CN106431941A/zh
Priority to PCT/PL2009/000004 priority patent/WO2009093916A2/en
Publication of PL384304A1 publication Critical patent/PL384304A1/pl
Publication of PL212489B1 publication Critical patent/PL212489B1/pl
Priority to US13/853,542 priority patent/US8841347B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL384304A 2008-01-22 2008-01-22 Pochodne fenoksyalkiloaminoalkanoli i ich zastosowania PL212489B1 (pl)

Priority Applications (14)

Application Number Priority Date Filing Date Title
PL384304A PL212489B1 (pl) 2008-01-22 2008-01-22 Pochodne fenoksyalkiloaminoalkanoli i ich zastosowania
RU2010133174/04A RU2515213C2 (ru) 2008-01-22 2009-01-19 Производные аминоалканолов, способ получения аминоалканолов и их применение
JP2010544256A JP5683965B2 (ja) 2008-01-22 2009-01-19 アミノアルカノールの誘導体、アミノアルカノールを得る方法及びそれらの使用
KR1020107016398A KR101610972B1 (ko) 2008-01-22 2009-01-19 아미노알칸올 유도체, 아미노알칸올의 제조 방법 및 이의 용도
ES09704454.9T ES2525544T3 (es) 2008-01-22 2009-01-19 Derivados de aminoalcanoles, método de obtención de aminoalcanoles y su uso
DK09704454.9T DK2247571T3 (en) 2008-01-22 2009-01-19 DERIVATIVES OF aminoalkanols, METHOD FOR OBTAINING aminoalkanols AND THEIR USE
BRPI0905726-9A BRPI0905726A2 (pt) 2008-01-22 2009-01-19 Derivado de aminoalcanol, composto, uso do derivado de aminoacanol, método de obtenção de derivados de aminoalcanóis e método de obtenção de aminoalcanóis
CA2712222A CA2712222C (en) 2008-01-22 2009-01-19 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
EP09704454.9A EP2247571B1 (en) 2008-01-22 2009-01-19 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
US12/863,881 US8633251B2 (en) 2008-01-22 2009-01-19 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
CN2009801026627A CN101932551A (zh) 2008-01-22 2009-01-19 氨基烷醇衍生物,氨基烷醇的制备方法及其用途
CN201610282236.8A CN106431941A (zh) 2008-01-22 2009-01-19 氨基烷醇衍生物，氨基烷醇的制备方法及其用途
PCT/PL2009/000004 WO2009093916A2 (en) 2008-01-22 2009-01-19 Derivatives of aminoalkanols, method of obtaining aminoalkanols and their use
US13/853,542 US8841347B2 (en) 2008-01-22 2013-03-29 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL384304A PL212489B1 (pl) 2008-01-22 2008-01-22 Pochodne fenoksyalkiloaminoalkanoli i ich zastosowania

Publications (2)

Publication Number Publication Date
PL384304A1 true PL384304A1 (pl) 2009-08-03
PL212489B1 PL212489B1 (pl) 2012-10-31

Family

ID=40677792

Family Applications (1)

Application Number Title Priority Date Filing Date
PL384304A PL212489B1 (pl) 2008-01-22 2008-01-22 Pochodne fenoksyalkiloaminoalkanoli i ich zastosowania

Country Status (12)

Country Link
US (2) US8633251B2 (pl)
EP (1) EP2247571B1 (pl)
JP (1) JP5683965B2 (pl)
KR (1) KR101610972B1 (pl)
CN (2) CN101932551A (pl)
BR (1) BRPI0905726A2 (pl)
CA (1) CA2712222C (pl)
DK (1) DK2247571T3 (pl)
ES (1) ES2525544T3 (pl)
PL (1) PL212489B1 (pl)
RU (1) RU2515213C2 (pl)
WO (1) WO2009093916A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229536B (zh) * 2011-04-25 2013-11-13 上虞市众昌化工有限公司 一种膜法电渗析分离氨基烷基醇的方法
US9488663B2 (en) 2013-03-14 2016-11-08 Abbott Point Of Care Inc. Electrochemical methods and devices for amending urine samples for immunosensor detection
US9651547B2 (en) 2013-03-14 2017-05-16 Abbott Point Of Care Inc. Electrochemical methods and devices for amending urine samples for immunosensor detection
PL225258B1 (pl) * 2013-08-09 2017-03-31 Univ Jagiellonski Nowe pochodne N-[(fenoksy)etoksy]alkiloaminoalkanoli oraz ich zastosowanie do wytwarzania leków
BR102013020313B1 (pt) * 2013-08-09 2021-07-06 Fundação Oswaldo Cruz derivados bifeniloxi-alquil-aminas e ariloxi-alquil-aminas, e, composição farmacêutica
KR20160068494A (ko) * 2014-12-05 2016-06-15 삼성전자주식회사 터치 입력을 처리하는 전자 장치 및 터치 입력을 처리하는 방법
KR101864085B1 (ko) 2017-09-22 2018-06-01 동아대학교 산학협력단 발프로산 유도체, 이의 제조방법 및 이를 포함하는 항경련제
CN109646426B (zh) * 2019-01-09 2022-01-25 成都倍特药业股份有限公司 一种组合物及1-氨基-2-丙醇纯度和有关物质的检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688639A (en) * 1951-07-17 1954-09-07 Givaudan Corp Nu-(beta-phenoxyethyl) ethanolamines
US3453308A (en) * 1966-10-14 1969-07-01 Parke Davis & Co Aryloxyalkylaminoethyl thiosulfate compounds
CH556817A (de) * 1969-09-24 1974-12-13 Ici Ltd Verfahren zur herstellung von alkanolaminderivaten.
US4071552A (en) * 1976-05-19 1978-01-31 Ayerst Mckenna And Harrison Ltd. Aryloxy aminobutanols, their preparation and use thereof
ZW9580A1 (en) * 1979-05-21 1981-12-23 Ici Ltd 1-phenyl-2-aminoethanol derivatives
JPS61291555A (ja) * 1985-06-18 1986-12-22 Suntory Ltd Ｎ−置換グルタミン酸およびその用途
IT1217900B (it) * 1988-06-23 1990-03-30 Mini Ricerca Scient Tecnolog Composti eterociclici azotati ad azione antifungina
JPH0971557A (ja) * 1995-09-06 1997-03-18 Fuji Photo Film Co Ltd アミノ基含有安息香酸エステル誘導体
PL319557A1 (en) 1997-04-18 1998-10-26 Univ Jagiellonski Collegium Me N-[(4-methyl- or 2,6-dimethylphenoxy)-ethyl]-amino alkanoles as well as n-[(4-methyl-or 2,6-dimethylphenoxy)-ethyl]-4-(aryl)-1 piperazines
KR100589474B1 (ko) * 1998-03-26 2006-06-14 산텐 세이야꾸 가부시키가이샤 신규한 우레아 유도체
AR020142A1 (es) * 1998-08-11 2002-04-10 Smithkline Beecham Corp Un compuesto derivado de arginina, una composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento paraantagonizar un receptor para c3a
US7465738B2 (en) * 2003-06-16 2008-12-16 Vertex Pharmaceuticals Incorporated Compounds useful as promoters of SMN2
US8883841B2 (en) * 2005-11-23 2014-11-11 The Board Of Regents Of The University Of Texas System Oncogenic ras-specific cytotoxic compound and methods of use thereof
JP2007182404A (ja) * 2006-01-10 2007-07-19 Hokko Chem Ind Co Ltd アリールオキシ−ｎ−（アルコキシアルキル）アルカン酸アミド誘導体および除草剤

Also Published As

Publication number Publication date
RU2515213C2 (ru) 2014-05-10
ES2525544T3 (es) 2014-12-26
CA2712222C (en) 2016-07-05
JP5683965B2 (ja) 2015-03-11
US20130289118A1 (en) 2013-10-31
US20110028562A1 (en) 2011-02-03
DK2247571T3 (en) 2014-12-08
EP2247571A2 (en) 2010-11-10
CA2712222A1 (en) 2009-07-30
JP2011510070A (ja) 2011-03-31
WO2009093916A2 (en) 2009-07-30
BRPI0905726A2 (pt) 2015-07-14
CN101932551A (zh) 2010-12-29
US8841347B2 (en) 2014-09-23
US8633251B2 (en) 2014-01-21
KR101610972B1 (ko) 2016-04-08
PL212489B1 (pl) 2012-10-31
CN106431941A (zh) 2017-02-22
RU2010133174A (ru) 2012-02-27
EP2247571B1 (en) 2014-09-10
KR20100127203A (ko) 2010-12-03
WO2009093916A3 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
PL384304A1 (pl) Pochodne fenoksyalkiloaminoalkanoli i ich zastosowania
PH12020500065A1 (en) Methods of treating epilepsy or status epilepticus
UA104613C2 (en) Alkylamine-substituted dicyanopyridines and amino acid ester prodrugs thereof
DK1999160T3 (da) Acryleret hyaluronsyre
AU2012272970A8 (en) Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
MY178905A (en) Prevention, treatment and diagnosis of p.gingivalis infection
UA104897C2 (uk) Спосіб поліпшення росту сіянців та/або раннього проростання культур
EP2593104A4 (en) PROCESS FOR TREATING AND PREVENTING / REDUCING THE PROBABILITY OF MESIAL TEMPORARY PEPPER (TLE)
MA32255B1 (fr) Procede pour la preparation de triamides a partir d'ammmoniac et d'amidodichlorures
MX2009011346A (es) Tapentadol para tratamiento de dolor con artritis.
MY151104A (en) Novel use
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
UA94176C2 (ru) Способ обработки пищевого продукта
UA102097C2 (ru) Способ лечения воспалительного заболевания с применением соединения, которое нейтрализует gm-csf, и соединения, которое нейтрализует il-17
BR112012022255A2 (pt) composição farmaceuticaestabilizada
WO2010102154A3 (en) Biaryl oxyacetic acid compounds
MX2011012140A (es) Ranolazina para el tratamiento de problemas del snc.
FR2954945B1 (fr) Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
WO2011073370A3 (fr) Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée
WO2008039327A3 (en) Method of treatment using fatty acid synthesis inhibitors
EP3973958A3 (en) Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders
EP2660313A4 (en) MEDIUM FOR TRANSFORMING CORYNEFORMER BACTERIA AND METHOD FOR PRODUCING ANILINE THEREWITH
UA96951C2 (ru) ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЯ КАК ЛЕКАРСТВЕННЫХ СРЕДСТВ
AU2019268209A1 (en) Compounds for the treatment of seizures and other central nervous system disorders and conditions
WO2010083241A3 (en) 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders